首页 | 本学科首页   官方微博 | 高级检索  
     

左旋咪唑或联合中药治疗复发性阿弗他口腔溃疡的系统评价与Meta分析
引用本文:张一凡,覃璇,林娟,张晓燕,覃仁安. 左旋咪唑或联合中药治疗复发性阿弗他口腔溃疡的系统评价与Meta分析[J]. 口腔医学研究, 2015, 31(5): 479
作者姓名:张一凡  覃璇  林娟  张晓燕  覃仁安
作者单位:1. 广东药学院中药学院 广东 广州 510006;2. 广州医科大学口腔学院;3. 广州白云山和记黄埔中药有限公司;4. 广州医药研究总院
基金项目:广州市“121人才梯队工程”专项资金资助项目(穗人社发[2011]167号)
摘    要:目的:系统评价左旋咪唑单独用药及联合中药治疗复发性阿弗他口腔溃疡的有效性和安全性。方法:计算机检索Cochrane图书馆、PubMed、CNKI、万方数据库在线知识服务平台,纳入有关左旋咪唑及联合中药治疗复发性阿弗他口腔溃疡的随机对照试验,根据Cochrane Reviewer’s Handbook 5.0.2评价标准和工具对纳入的研究进行质量评价,并使用RevMan5.2软件进行统计分析。结果:左旋咪唑单独用药共纳入9个随机对照试验,共331例患者,治疗组有效性高于安慰剂组,其差异具有统计学意义(OR=4.92,95%CI[2.14,11.32],P=0.0002),共有46例患者出现不良反应。左旋咪唑联合中药共纳入16个随机对照试验,共1854例患者,治疗组RAU的有效性明显高于对照组,其差异具有统计学意义(OR=5.97,95%CI[4.40,8.10],P<0.00001),无不良反应报道。结论:左旋咪唑联合中药用于复发性阿弗他口腔溃疡较单独采用左旋咪唑效果更好,并且避免了左旋咪唑单独用药副作用大的缺点,具有较好的临床研究和运用前景。但本系统评价纳入研究文献质量较差,增加了本次系统评价结论产生偏倚的风险,期待有高质量的临床试验报道。

关 键 词:左旋咪唑  中西医结合  复发性阿弗他口腔溃疡  系统评价  Meta分析  
收稿时间:2014-09-19

Systematic Review and Meta Analysis of Levamisole or Combined with Traditional Chinese Medicine in the Treatment of Recurrent Aphthous Ulcer.
ZHANG Yi-fan,QIN Xuan,LIN Juan,et al.. Systematic Review and Meta Analysis of Levamisole or Combined with Traditional Chinese Medicine in the Treatment of Recurrent Aphthous Ulcer.[J]. Journal of Oral Science Research, 2015, 31(5): 479
Authors:ZHANG Yi-fan  QIN Xuan  LIN Juan  et al.
Affiliation:School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006
Abstract:Objective: To evaluate the effectivness and safety of levamisole in the treatment of recurrent aphthous ulcer. Methods: The databases such as Cochrane Library, PubMed, CNKI and Wanfang Data were searched by computer to include randomized controlled trails(RCTs) on levamisole in the treatment of recurrent aphthous ulcer. Studies were screened according to the inclusion and exclusion criterion. Data were extracted and the meta-analyses were performed by using RevMan 5.2 software. Results: 9 studies(331 patients) were included in the review of levamisole in treatment of RAU. The results of meta-analyses showed, compared with placebo group, levamisole was superior in improving RAU(OR=4.92,95%CI[2.14,11.32],P=0.0002). 46 patients were reported adverse reactions. 16 studies(1854 patients) were included in the review of levamisole combined with traditional chinese medicine in treatment of RAU. The results of meta-analyses showed, compared with placebo group, levamisole was superior in improving RAU(OR=4.92,95%CI[2.14,11.32],P=0.0002). No one were reported with adverse reactions. Conclusion: Current evidences show that levamisole combined with TCM is likely to be more effective and safety in the treatment of RAU than using levamisole only. However, for the limited evidence and lower methodological quality of the included studies, this conclusion still needs to be verified with more high-quality RCTs.
Keywords:Levamisole   Traditional   Chinese medicine   Recurrent aphthous ulcer   Systematical review  Meta analysis  
点击此处可从《口腔医学研究》浏览原始摘要信息
点击此处可从《口腔医学研究》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号